Review Med Lp Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Insurance

Industry

Estimated Revenue & Valuation

  • Review Med Lp's estimated annual revenue is currently $7.9M per year.(i)
  • Review Med Lp's estimated revenue per employee is $176,000

Employee Data

  • Review Med Lp has 45 Employees.(i)
  • Review Med Lp grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$139.7M5083%N/AN/A
#2
$44.8M18585%N/AN/A
#3
$14.5M734%N/AN/A
#4
$25.7M117-1%N/AN/A
#5
$180.1M65523%N/AN/A
#6
$6.2M35-29%N/AN/A
#7
$132.8M48326%N/AN/A
#8
$4.3M28-3%N/AN/A
#9
$0.4M4-33%N/AN/A
#10
$7M4025%N/AN/A
Add Company

Review Med is a Dallas-based medical cost containment firm that helps manage workers' compensation claims and other managed care issues. Review Med's services include disability management services, medical review services and medical bill audits, among others. Founded in 1997, Review Med is one of Texas' largest providers of medical containment services, with personnel in Dallas, Austin, Houston and San Antonio. At Review Med, we're about doing the right thing. Let us help you.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$7.9M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Review Med Lp News

2022-04-20 - Temporal trends in associations between severe mental ...

... of cardiovascular disease: A systematic review and meta-analysis ... PLoS Med 19(4): e1003960. https://doi.org/10.1371/journal.pmed.

2022-04-13 - Systematic reviews and meta-analysis published in indexed ...

Sixty-six systematic reviews published in 5 Portuguese medical ... For each of the eligible systematic reviews, three reviewers (LP,...

2022-04-06 - Identification of tools used to assess the external validity of ...

The aim of this review was to identify tools to assess the external validity of RCTs. ... Evid Based Med 2006;11:35 LP– 38.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.7M45N/AN/A
#2
$9.2M45N/AN/A
#3
$7.2M4541%N/A
#4
$8.8M45-13%N/A
#5
$5.2M4522%N/A